RU-HIST D- brompheniramine maleate and phenylephrine hydrochloride tablet, coated 
Allegis Pharmaceuticals, LLC

----------

Ru-Hist D

Tablet

Drug Facts

Active Ingredients
Each tablet contains:
Purpose
Brompheniramine Maleate 4 mgAntihistamine
Phenylephrine HCl 10 mgNasal Decongestant

Uses

Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

Warnings

Do not exceed recommended dosage.

Do not use this product

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

Ask a doctor before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes mellitus
  • difficulty in urination due to enlargement of the prostate gland

Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor.

When using this product

  • excitability may occur, especially in children
  • may cause drowsiness
  • alcohol, sedatives and tranquilizers may increase drowsiness
  • avoid alcoholic beverages
  • use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

  • nervousness, dizziness, or sleeplessness occur
  • if symptoms do not improve within 7 days or are accompanied by fever
  • new symptoms occur

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children.

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

Do not exceed recommended dosage.

Adults and children 12 years of age and over:1 tablet every 4 hours, not to exceed 6 tablets in 24 hours, or as directed by a doctor
Children 6 to under 12 years of age:1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor
Children under 6 years of age:Consult a doctor

Other information

Store at 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].

Inactive ingredients

Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate

Questions or Comments?

Call 866-633-9033

PRINCIPAL DISPLAY PANEL - 60 Tablet Bottle Label

NDC 28595-900-60

Ru-Hist D
Antihistamine • Nasal Decongestant

Each tablet contains:
Brompheniramine Maleate    4 mg
Phenylephrine HCl    10 mg

Tamper evident by foil seal under cap. Do not use if foil seal
is broken or missing.

New Formula

ALLEGIS PHARMACEUTICALS

Manufactured for:
Allegis Pharmaceuticals, LLC
Canton, MS 39046

60 Tablets

Principal Display Panel - 60 Tablet Bottle Label
RU-HIST D 
brompheniramine maleate and phenylephrine hydrochloride tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:28595-900
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BROMPHENIRAMINE MALEATE (UNII: IXA7C9ZN03) (BROMPHENIRAMINE - UNII:H57G17P2FN) BROMPHENIRAMINE MALEATE4 mg
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Product Characteristics
ColorwhiteScoreno score
ShapeOVALSize14mm
FlavorImprint Code 300
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:28595-900-6060 in 1 BOTTLE; Type 0: Not a Combination Product11/01/2013
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01211/01/2013
Labeler - Allegis Pharmaceuticals, LLC (792272861)

Revised: 1/2024
Document Id: 0e768a0e-1c4e-7a5b-e063-6394a90a8097
Set id: 1a93fa51-94fb-434b-913f-b2424cf4d968
Version: 4
Effective Time: 20240108
 
Allegis Pharmaceuticals, LLC